Ely Benaim, Chief Medical Officer at NovoCure Ltd (NVCR), sold 5,190 shares at $64.78 ($336K) on 2020-05-12, disclosed to the SEC on 2020-05-14.
Open-market sale of $336k NVCR by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.78 | 2,595 | $168K | 50.0% |
| 2 | $64.78 | 2,595 | $168K | 50.0% |
| Total | $64.78 avg | 5,190 | $336K | 100% |
| Filing → |
| NVCR | SELL | 2022-05-12 | $531K | — | Filing → |
| NVCR | SELL | 2022-03-07 | $332K | — | Filing → |
| NVCR | SELL | 2021-08-04 | $139K | — | Filing → |